Eveliqure Biotechnologies
EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Eveliqure Biotechnologies Information
Geographic Data
Address:
City: Vienna
State: Wien
Zip:
Country: Austria
Financial Info
Stage:
series a
Raised Last:
$3M
Raised Total:$3M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one of the two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2015 | Venture Round | 1 | - |
Kinled Holding Kinled Holding |
7/2019 | Series A | $0 |
Arax Capital Partners Arax Capital Partners |
7/2019 | Series A | 1 | $2.8M |
Arax Capital Partners Arax Capital Partners |
1/2015 | Venture Round | 1 | - |
Kinled Holding Kinled Holding |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
